Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab

Purpose. To evaluate antiangiogenic effect of local use of bevacizumab (anti-VEGF antibody) in patients with corneal neovascularization. Methods. Patients were divided into two groups. All patients suffered from some form of corneal neovascularization (NV). Patients in group A received 0.2–0.5 mL of...

Descripción completa

Detalles Bibliográficos
Autores principales: Krizova, Deli, Vokrojova, Magdalena, Liehneova, Katerina, Studeny, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981012/
https://www.ncbi.nlm.nih.gov/pubmed/24778865
http://dx.doi.org/10.1155/2014/178132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981012/
https://www.ncbi.nlm.nih.gov/pubmed/24778865
http://dx.doi.org/10.1155/2014/178132

Ejemplares similares